Gulf War Syndrome Clinical Trial
Official title:
Beyond Benefits of Q10: Mitochondrial Cocktail for Gulf War Illness
NCT number | NCT02804828 |
Other study ID # | GW140146 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 9, 2021 |
Est. completion date | April 3, 2023 |
Verified date | April 2023 |
Source | University of California, San Diego |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to develop preliminary evidence, such as effect size and variance estimates, to guide successful conduct of a properly-powered clinical trial to assess the benefit of a mitochondrial cocktail (incorporating individualization of treatment) in Gulf War illness (GWI).
Status | Completed |
Enrollment | 15 |
Est. completion date | April 3, 2023 |
Est. primary completion date | April 3, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 48 Years and older |
Eligibility | Inclusion Criteria: - Meet symptom criteria for Gulf War illness with BOTH the Centers for Disease Control and Prevention (CDC) Criteria (persistent symptoms in at least 2 of 3 designated symptom domains of fatigue/sleep, mood/cognition, and musculoskeletal) and Kansas Criteria (score a moderate or severe rating in at least 3 of the 6 symptom domains of fatigue, pain, neurological/cognitive/mood, skin, GI and respiratory). Exclusion Criteria: - Have conditions like multiple sclerosis or lupus that can produce similar symptoms and be confused for Gulf War illness. - Participating in a concurrent treatment trial. - Unwilling or unable to comply with the treatment protocol - Failed run-in; do not take at least 80% of run-in medications |
Country | Name | City | State |
---|---|---|---|
United States | UC San Diego | La Jolla | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Diego |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean change in single item General Self-Rated Health Visual Analog Scale from baseline | 0, 3, 6 months (double-blind phase) | ||
Primary | Percent improved on Gulf War Illness Modified Lower Extremity Performance Score/timed chair rises | 6 months (double-blind phase) | ||
Primary | Number of symptoms (out of 20 on the UCSD Symptom Score Survey) showing more favorable change (trend or effect) on active treatment vs. placebo | 0, 3, 6 months (double-blind phase) | ||
Primary | Mean change of CoQ10 and Vitamin E levels, comparing active treatment to placebo | 6 months (double-blind phase) | ||
Secondary | Assessment of summed symptom score (sum of ratings for UCSD GWI symptom index) | Secondary measures will incorporate assessment of summed symptom score (sum of ratings for UCSD GWI symptom index) at primary endpoint time point. We will assess at additional time points (9, 12 month) and will assess effects stratified by sex; by dominant ethnicity; and by use of medications that can affect levels or disposition of supplement components (e.g. statin use). | 6, 9, 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00129454 -
Telemedicine Treatment for Veterans With Gulf War Illness
|
N/A | |
Completed |
NCT00100412 -
Hyporeactivity and Gulf War Illness
|
N/A | |
Recruiting |
NCT04182659 -
Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms
|
N/A | |
Recruiting |
NCT04987775 -
GWICTIC: NAC Mechanistic Study in Gulf War Veterans
|
Early Phase 1 | |
Completed |
NCT03342482 -
Glutamate Neuro-Excitotoxicity in GWI
|
N/A | |
Completed |
NCT01264471 -
Mechanisms of Mitochondrial Defects in Gulf War Syndrome
|
N/A | |
Terminated |
NCT03547869 -
Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.
|
N/A | |
Recruiting |
NCT05675878 -
Confirmation of Diet as a Treatment for Gulf War Illness
|
Phase 3 | |
Recruiting |
NCT05736146 -
Validating Gulf War Illness Blood Biomarkers
|
||
Completed |
NCT03560830 -
START & STOPP in GWI
|
||
Recruiting |
NCT05355272 -
Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
|
Phase 2 | |
Terminated |
NCT04712071 -
Ketamine in Veterans With Gulf War Illness
|
Early Phase 1 | |
Completed |
NCT03030794 -
Alleviating Headache and Pain in GWI With Neuronavigation Guided rTMS
|
N/A | |
Completed |
NCT04638998 -
Assessing Neuroinflammation in GWI Using MRS
|
||
Recruiting |
NCT02848417 -
Glutathione vs. Curcumin Clinical Trial
|
Phase 1/Phase 2 | |
Recruiting |
NCT00956150 -
Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex
|
Phase 1 | |
Completed |
NCT00018707 -
Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress
|
N/A | |
Not yet recruiting |
NCT05992311 -
Clinical Evaluation of Montelukast in Veterans With Gulf War Illness
|
Phase 1 |